SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-094561
Filing Date
2021-03-25
Accepted
2021-03-25 16:47:32
Documents
9
Effectiveness Date
2021-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 d120724ds8.htm S-8 70000
2 EX-5.1 d120724dex51.htm EX-5.1 10993
3 EX-23.1 d120724dex231.htm EX-23.1 1541
4 EX-99.2 d120724dex992.htm EX-99.2 73363
5 EX-99.3 d120724dex993.htm EX-99.3 65350
6 EX-99.5 d120724dex995.htm EX-99.5 63010
7 EX-99.6 d120724dex996.htm EX-99.6 34210
8 GRAPHIC g120724g0325035042274.jpg GRAPHIC 2771
9 GRAPHIC g120724g0325035042445.jpg GRAPHIC 1546
  Complete submission text file 0001193125-21-094561.txt   325885
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254705 | Film No.: 21772991
SIC: 2834 Pharmaceutical Preparations